IL159404A0 - Pharmaceutical formulation having a masked taste and method for the production thereof - Google Patents

Pharmaceutical formulation having a masked taste and method for the production thereof

Info

Publication number
IL159404A0
IL159404A0 IL15940402A IL15940402A IL159404A0 IL 159404 A0 IL159404 A0 IL 159404A0 IL 15940402 A IL15940402 A IL 15940402A IL 15940402 A IL15940402 A IL 15940402A IL 159404 A0 IL159404 A0 IL 159404A0
Authority
IL
Israel
Prior art keywords
production
pharmaceutical formulation
masked taste
masked
taste
Prior art date
Application number
IL15940402A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL159404A0 publication Critical patent/IL159404A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15940402A 2001-06-21 2002-06-21 Pharmaceutical formulation having a masked taste and method for the production thereof IL159404A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (1)

Publication Number Publication Date
IL159404A0 true IL159404A0 (en) 2004-06-01

Family

ID=8864587

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15940402A IL159404A0 (en) 2001-06-21 2002-06-21 Pharmaceutical formulation having a masked taste and method for the production thereof
IL159404A IL159404A (en) 2001-06-21 2003-12-16 Pharmaceutical formulation having a masked taste and method for the production thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159404A IL159404A (en) 2001-06-21 2003-12-16 Pharmaceutical formulation having a masked taste and method for the production thereof

Country Status (42)

Country Link
US (2) US7138138B2 (xx)
EP (1) EP1401397B1 (xx)
JP (1) JP4880871B2 (xx)
CN (1) CN1239149C (xx)
AP (1) AP1595A (xx)
AR (1) AR036096A1 (xx)
AT (1) ATE290366T1 (xx)
AU (1) AU2002329311B2 (xx)
BG (1) BG66314B1 (xx)
BR (1) BRPI0208998A2 (xx)
CA (1) CA2452239C (xx)
CO (1) CO5540278A2 (xx)
CZ (1) CZ299947B6 (xx)
DE (1) DE60203178T2 (xx)
EA (1) EA006016B1 (xx)
EC (1) ECSP034915A (xx)
ES (1) ES2236574T3 (xx)
FR (1) FR2826274B1 (xx)
GT (2) GT200200115AA (xx)
HK (1) HK1067558A1 (xx)
HR (1) HRP20031067B1 (xx)
HU (1) HUP0400799A3 (xx)
IL (2) IL159404A0 (xx)
JO (1) JO2325B1 (xx)
MA (1) MA27042A1 (xx)
MX (1) MXPA03011756A (xx)
MY (1) MY134340A (xx)
NO (1) NO332258B1 (xx)
NZ (1) NZ530042A (xx)
OA (1) OA12635A (xx)
PA (1) PA8548301A1 (xx)
PE (1) PE20030201A1 (xx)
PL (1) PL202090B1 (xx)
PT (1) PT1401397E (xx)
SK (1) SK285865B6 (xx)
SV (1) SV2003001098A (xx)
TN (1) TNSN03141A1 (xx)
TW (1) TWI228049B (xx)
UA (1) UA77960C2 (xx)
UY (1) UY27341A1 (xx)
WO (1) WO2003000225A2 (xx)
ZA (1) ZA200309479B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
ES2427724T3 (es) * 2006-02-03 2013-10-31 Evonik Röhm Gmbh Composiciones farmacéuticas, que contienen mezclas de polímeros y de sustancias activas difícilmente solubles en agua
US20100226979A1 (en) * 2006-03-21 2010-09-09 Jubilant Organosys Limited Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
AU2009328762B2 (en) 2008-12-16 2015-07-23 Carlsberg A/S Coating of hydroxylated surfaces by gas phase grafting
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
US20170224664A1 (en) * 2014-08-05 2017-08-10 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
WO1999017742A2 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations
IN191239B (xx) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
WO2002016380A1 (en) * 2000-08-22 2002-02-28 Basilea Pharmaceutica Ag New macrolides with antibacterial activity

Also Published As

Publication number Publication date
FR2826274A1 (fr) 2002-12-27
AR036096A1 (es) 2004-08-11
DE60203178D1 (de) 2005-04-14
CN1529585A (zh) 2004-09-15
WO2003000225A2 (fr) 2003-01-03
NO20035581D0 (no) 2003-12-15
MXPA03011756A (es) 2004-07-01
JO2325B1 (en) 2006-06-28
GT200200115AA (es) 2005-01-12
PA8548301A1 (es) 2003-09-05
PL366803A1 (en) 2005-02-07
AU2002329311B2 (en) 2007-02-01
BRPI0208998A2 (pt) 2017-06-06
HUP0400799A3 (en) 2012-08-28
FR2826274B1 (fr) 2003-09-26
PT1401397E (pt) 2005-05-31
CZ20033441A3 (en) 2004-03-17
AP2003002927A0 (en) 2003-12-31
GT200200115A (es) 2003-02-27
US20040142029A1 (en) 2004-07-22
CA2452239C (fr) 2011-07-19
EA200400061A1 (ru) 2004-06-24
CN1239149C (zh) 2006-02-01
HUP0400799A2 (hu) 2004-08-30
PE20030201A1 (es) 2003-03-12
AP1595A (en) 2006-04-12
EP1401397A2 (fr) 2004-03-31
MY134340A (en) 2007-12-31
NO332258B1 (no) 2012-08-13
TNSN03141A1 (fr) 2005-12-23
UA77960C2 (en) 2007-02-15
BG108458A (bg) 2005-02-28
DE60203178T2 (de) 2006-01-26
CO5540278A2 (es) 2005-07-29
JP4880871B2 (ja) 2012-02-22
CZ299947B6 (cs) 2009-01-07
ES2236574T3 (es) 2005-07-16
JP2004534810A (ja) 2004-11-18
IL159404A (en) 2007-08-19
TWI228049B (en) 2005-02-21
WO2003000225A3 (fr) 2003-03-13
SV2003001098A (es) 2003-03-18
ZA200309479B (en) 2005-04-26
NZ530042A (en) 2005-09-30
PL202090B1 (pl) 2009-06-30
EA006016B1 (ru) 2005-08-25
OA12635A (fr) 2006-06-15
HRP20031067A2 (en) 2004-04-30
CA2452239A1 (fr) 2003-01-03
US7138138B2 (en) 2006-11-21
ECSP034915A (es) 2004-02-26
US20070014857A1 (en) 2007-01-18
ATE290366T1 (de) 2005-03-15
HK1067558A1 (en) 2005-04-15
SK285865B6 (sk) 2007-10-04
BG66314B1 (bg) 2013-04-30
SK15922003A3 (sk) 2004-05-04
EP1401397B1 (fr) 2005-03-09
UY27341A1 (es) 2003-01-31
HRP20031067B1 (en) 2011-10-31
MA27042A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
HK1067558A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
IL159031A0 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
AU2003259417A1 (en) Taste masked dosage forms and processes for their preparation
AU2002344151A1 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
AU2002303973A1 (en) Pharmaceutical dispensing apparatus and method
EP1478345A4 (en) NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
AU2002251612A1 (en) Stent and method for the production thereof (variants)
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
HUP0401200A3 (en) Pharmaceutical compositiuons containing terbinafin and process for producing them
GB0009349D0 (en) Shell-type confectionery product and method for manufacturing the same
AU2001295579A1 (en) Pants and method for the production thereof
EP1581258A4 (en) PHARMACEUTICAL FORMULATION AND MANUFACTURING METHOD THEREFOR
AU2002242685A1 (en) Creamy foodstuff and method for production thereof
MXPA03006501A (es) Producto alimenticio cremoso y metodo para su eleboracion.
AU2003281698A8 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
HUP0105345D0 (en) Amlodipine bezylate tablets having extended stability and process for producing the same
HK1071524A1 (en) Coated tablets and process for producing the same
SI1401397T1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof
AU2002363843A1 (en) Packing material and method for the production thereof
AU2002250813A1 (en) Pesticide and method for the production thereof
EP1374702A4 (en) FLAVORS AND METHOD FOR THEIR PRODUCTION
GB0112640D0 (en) Process and product
AU2002342493A1 (en) Angular decoration-holding device and method for the production thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed